Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Novozymes has agreed to acquire the Australian biotechnology company GroPep for almost $65 million. GroPep manufactures Long R3 IGF-1, a growth factor supplement used to produce vaccines, monoclonal antibodies, and other recombinant proteins in mammalian cell-based manufacturing systems that don't use animal serum as a cell nutrient source. GroPep had sales last year of $12.7 million, almost all from Long R3 IGF-1.
This article has been sent to the following recipient: